Part 1 of our series, "Understanding INET."
This article is educational in nature and does not replace personalised medical advice. If you are managing a health condition, please consult a qualified practitioner.
Homotoxicology was, in its own right, the first major innovation in homeopathy since Hahnemann — Hans-Heinrich Reckeweg's attempt to interpret Hahnemann's original principles through the medical culture of the 1930s, 40s and 50s, the decades in which biochemistry and immunology became the protagonists of modern medicine. It kept its roots firmly in classical homeopathy while drawing widely on scientific medicine, and in particular on molecular biology and neuroendocrine immunology. INET is the next chapter in that same story: a further, more focused development that GUNA built directly on homotoxicology's foundations.
A Compound Medicine With Two Defining Properties
Before INET can make sense, it helps to understand what a homotoxicological compound actually is, because INET inherits its structure directly. A homotoxicological compound has two defining properties. The first is the sheer variety of remedies it can draw on — everything from nosodes to Krebs cycle catalysts, from Quinone to organotherapeutic Suis preparations, from classic homeopathic remedies to homeopathised allopathic products. The second is that these remedies are combined according to Burgi's Principle: synergism, complementarity and completeness working together, rather than a single active ingredient working alone.
It was within the Associazione Italiana di Omotossicologia (AIOT), the Italian medical association of homotoxicology, that this compound approach was pushed further. In 1990, GUNA published the first study to introduce the theoretical concepts of Psycho-Neuro-Endocrino-Immunology, or PNEI, into homotoxicology — a step that would eventually give rise to INET.
Why PNEI Changed the Picture
PNEI's central claim is that the body's three great homeostatic systems — endocrine, immune and nervous — are not separate departments but a single interconnected network. In 1991 and 1992, the researcher J.E. Blalock demonstrated something that gave this claim real teeth: immune cells such as lymphocytes and macrophages are themselves neuroendocrine cells, "biological units" capable of both receiving and transmitting neurohormonal signals. Subsequent studies in neuroendocrinology, going back over recent decades, have further revealed the neuroendocrine activity of neurones themselves, and confirmed the presence of hormone receptors at both the cell membrane and the intracellular level.
"The homeostatic balance of cells requires two basic conditions: the functional integrity of the Neuroendocrine Axis, and Neuroendocrine Homeostasis of the membrane and its receptors."
This is the insight that reframes conditions once treated as separate, organ-specific complaints. Neurovegetative dystonia, cardiac neurosis and spastic colitis, for instance, were once understood as isolated, almost purely symptomatic states of particular organs. With a fuller picture of the neuroendocrine system, these are better understood as physiopathological problems with genuinely integrated biological roots — expressions of the same underlying network rather than unrelated local events.
The Brain as First Mediator, and the Role of the VNS
Within this holistic interpretation, the Central Nervous System holds the fundamental role of activating impulses which travel to organs and peripheral systems and, eventually, return to the CNS itself as signals. Because of this unitary role of action and control, the brain can reasonably be defined as the first mediator of the whole network.
Alongside the CNS sits the Vegetative Nervous System, or VNS, which acts as the linking structure between the brain and the organs. The VNS carries functional messages from the brain to the periphery, and it connects the brain, organs and endocrine glands with the immune network — which, in turn, modulates and activates the functions of the organs and the CNS. This interconnection between the CNS and the immune system provides clear, checkable biological and physiopathological signals, running in an unbroken chain from the cerebrum down through the pineal gland, hypophysis, thyroid, thymus, pancreas, gonads and adrenal glands, with the spleen linked into the same network.
Two Therapeutic Methods, Working Together
Reasoning from this model, and after extensive clinical study within AIOT aimed at proving the effectiveness of Neuro-Endocrino-Immunology therapy in chronic degenerative pathologies, GUNA arrived at a specific therapeutic strategy: Integrated Neuro Endocrine Therapy, or INET. Its premise is that a chronic pathology causes a "deregulation" of neuroendocrine homeostasis at the level of the membrane receptors — a deregulation that can, over time, lead to cell damage. Reversing this requires what GUNA describes as neuroendocrine reprogramming of the cell membrane, bringing it back into homeostasis.
Two therapeutic methods are considered vital to achieving this: the administration of Suis organs, particularly glandular ones, which have a well-documented modulating action on target tissues in the homeopathic dilutions used in INET compounds; and the administration of hormonal substances themselves, in a concentration that is physiological for the cells — a concentration GUNA notes is consistent with the homeopathic concept of dilution.
Where INET Fits Alongside Other Approaches
INET is not presented as a replacement for existing frameworks, but as what GUNA calls the central therapeutic nucleus for degenerative endocrine pathology in general, with the exception of endocrine-dependent tumours. Depending on the case, it can be combined with classic homeopathic therapy, with homotoxicology in the proper sense of the term, or with allopathic medicine — and in chronic patients already on allopathic therapy, INET is often combined with classic homotoxicology specifically to help assess, with real caution, any possible change in the dosing of drugs such as glucocorticoids, psychotropic medication, NSAIDs or immunosuppressants.
Clinically, GUNA reports encouraging results across a range of chronic conditions: functional disorders of the menstrual cycle, climacteric syndrome, degenerative arthropathy, osteoporosis, andropause, anxious-depressive syndrome in the elderly, autoimmune diseases including Hashimoto's thyroiditis, pancreopathy, multiple sclerosis and syringomyelia, Basedow's disease, cerebral and polyregional vasculopathy in the elderly, mood disorders, and degenerative cardiopathy.
The Pharmacology Behind the Products
In practical terms, the Suis organotherapies at the heart of INET are prepared at the GUNA laboratories in Milan from their mother tincture, and supplied as oral drops in hydroalcoholic solution. The products themselves are organised into three groups of increasing complexity — a primary group built purely from Suis organotherapies of the neuroendocrine axis, a secondary group that adds single homeopathic remedies, vitamins and other substances with neuroendocrine activity, and a tertiary group formulated specifically as an adjunct in Type 1 diabetes. We look at each of these three groups, and the specific products within them, across the rest of this series — starting, in the next article, with the primary group: K2F and K2M.
Featured products
Explore the full Guna Endocrinology range — INET compounds and neuroendocrine support built on GUNA’s PNEI research.
Not sure which remedy is right for you?
Try our Natural Remedy Finder, or contact our team for guidance.
Related reading
- K2F and K2M: Restarting the Neuroendocrine Axis
- Senectus F and Senectus M: Supporting Healthy Ageing
- K2F-DIA and K2M-DIA: Adjunctive Neuroendocrine Support Alongside Insulin Therapy
Source: GUNA, *From Homotoxicology to INET (Integrated Neuro Endocrine Therapy)*, by Salvatore Matarese, M.D.
Tags: Guna Articles, Understanding INET, Homotoxicology, PNEI